SURGICAL CH
SPECIALISTS
LIMITED
BOWEL SURGERY
SERVICE FROM THE HEART
TABLE OF CONTENTS
|
01 |
Corporate |
|
profile |
|
|
02 |
of the president |
|
Message |
|
|
04 |
executive directors |
|
Statement |
|
|
10 |
Fiscal year 2022 |
|
In Review |
|
|
12 |
Performance |
|
Check |
|
|
14 |
Table of |
|
directors |
|
|
sixteen |
Wrench |
|
management |
|
|
17 |
Cluster |
|
Structure |
|
Our
Services
Our
specialists
Our general practitioners
Our
Equipment
Clinic Locations
Our Endoscopy Centers
Financial
Contents
Corporate information
|
East |
annual |
report |
has |
been prepared by |
|
HC Surgical Specialists Limited (“the Company”) |
||||
|
Y |
reviewed |
by |
the |
company Sponsor, |
Novus Corporate Finance Pte. Ltd. (the “Sponsor”), in accordance with Rule 226(2)(b) of Section B of the Securities Dealing Manual of the Singapore Stock Exchange (the “SGX-ST”): Catalyst rules.
This annual report has not been reviewed or approved by SGX-ST and SGX-ST assumes no responsibility for the content of this annual report, including the accuracy of any statements or opinions made, or reports contained in this annual report.
The contact person for the sponsor is Mr. Pong Chen Yih, COO, at 7 Temasek Boulevard, #18-03B Suntec Tower 1, Singapore 038987, telephone (65) 6950 2188.
HC Surgical Specialists Limited operates a extensive network of endoscopy clinics and centers across Singapore, providing specialist medical care at your doorstep, both in residential and central areas, making it conveniently accessible, with less waiting time and lower costs. As members of the same group, the clinics are dedicated to providing endoscopic procedures including gastroscopies and colonoscopies. Most of our clinics are equipped with the facilities to perform general surgery services with a focus on on-site colorectal surgery procedures. Our endoscopy centers aim to provide maximum comfort, efficiency and safety to all our patients. Our clinics are also accredited by Medisave and Medishield Life, allowing us to further improve our services for our patients.
|
02 |
HC SURGICAL SPECIALISTS LIMITED |
MESSAGE FROM THE PRESIDENT
With the COVID-19 pandemic situation now under control, many countries have opened their borders and life has pretty much returned to pre-pandemic mode. HCSS will continue to expand our network of specialists and centers both locally and regionally as opportunity arises.
DEAR SHAREHOLDERS,
On behalf of the Directors and Management of HC Surgical Specialists Limited (“HCSS” or “Company”, and together with its subsidiaries, collectively, the “Group”), I am pleased to present the HCSS Annual Report for the fiscal year ended 31 May (“fiscal year”) 2022.
Fiscal year 2022 began thanks to an exceptionally good performance in fiscal year 2021, which was due to pent-up demand after circuit breaker measures were lifted on June 2, 2020. However, it was a period in which the The nation saw a record number of COVID-19 cases and deaths as we transitioned to living with the COVID-19 pandemic before the situation was under control by the end of fiscal year 2022. The global situation was also not stable, with the Russia- Ukraine and the twin concerns of high inflation and the threat of a global recession. The Group’s performance took a hit as the number of patients seeking elective medical treatment fell, and even more so as COVID-19 restrictions were lifted and border restrictions were eased towards the end of FY2022, as many opted for traveling abroad.
However, the Group remained focused on its provision of medical services. During fiscal year 2022, the Group
- acquired the remaining 49% interest in Jason Lim Endoscopy and Surgery Pte. Ltd. (“JLES”) in August 2021; (ii) acquired the remaining 49% interest in Medical L & C Services Pte. Ltd. (“MLCS”) in September 2021, thereby owning 100% of JLES and MLCS; (iii) carried out an internal restructuring and closed the Mount Alvernia and Dleedon clinics;
- converted convertible bonds worth S$625,000 into shares of Nuffield Dental Holdings Private
Limited in October 2021; Y
- signed a lease for a new hub in eastern Singapore in May 2022. These are steps taken to generate long-term benefits for the Group.
FORWARD
Going forward, we are delighted to start the new financial year with the contract signed with AIA Singapore Private Limited (“AIA Singapore”) for another three-year period. With the COVID-19 pandemic situation now under control, many countries have opened their borders and life has returned to the way it was before the pandemic.
mode. HCSS will continue to expand our network of specialists and centers both locally and regionally as opportunity arises.
APPRECIATION
Last but not least, I would like to take this opportunity to thank our shareholders, patients, and business partners for their unwavering support of HCSS, my fellow directors for their invaluable insights over the past several years, and the staff and management for their dedication and commitment. .
This is an excerpt from the original content. To continue reading it, access the original document here.
Disclaimer
HC Surgical Specialists Ltd. posted this content on 05 September 2022 and is solely responsible for the information contained therein. Distributed by Public, without editing or altering, the September 05, 2022 02:09:02 UTC.
© PublicNow 2022
|
|
|
|
|
|
|
||||
|
||||
Technical Analysis Trends HC SURGICAL SPECIALISTS LIMITED
| short term | Medium term | Long-term | |
| Trends | Neutral | Bearish | Bearish |
Evolution of the Income Statement
